Given the distinct secretion profiles observed in CD4+ and CD8+ T cells from MG patients compared to HCs, we assessed the cellular metabolic activity using an MTT assay as an indirect measure of proliferation (Figure 8). This evidence concerns the gene CD8A and myasthenia gravis.